Paul Lerou, MD

Dr. Lerou received his medical degree from Jefferson Medical School and completed his residency and chief residency in Pediatrics at Boston Children’s Hospital, followed by a clinical fellowship in the Harvard Neonatal-Perinatal Medicine Fellowship Program. 

Dr. Lerou studies bronchopulmonary dysplasia (BPD), a chronic lung disease that is one of the most common complications of extreme prematurity. Clinical interventions to prevent and treat BPD are complex and expensive, yet not very effective—the incidence of this disorder is unchanged over the past several decades. Dr. Lerou’s group studies the role and function of mesenchymal and epithelial progenitor cells derived directly from tracheal secretions of intubated newborns across a spectrum of disease and developmental maturity. They integrate innovative single cell, bioengineering, and developmental biology techniques. Patient-specific lung progenitors will improve our understanding of BPD and in the future can be used in a precision medicine approach to prevent and treat this disease. After 10 years on staff at Brigham & Women’s Hospital, Lerou joined MGH as division of chief in neonatology and newborn medicine in 2015.

Outside of work, he enjoys spending time with his wife, their 3 teenage girls, and their 5 year old Labrador (yes, a boy!)